Cme Group Stock Working Capital
CME Stock | USD 215.60 2.72 1.28% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
As of March 28, 2024, Net Working Capital is expected to decline to about 1.3 B. The current year's Change In Working Capital is expected to grow to about (57.8 M). CME | Working Capital |
CME Working Capital Analysis
CME's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.9B | 4.3B | 4.5B | 2.5B | Total Revenue | 4.7B | 5.0B | 5.6B | 3.0B |
Working Capital | = | Current Assets | - | Current Liabilities |
Current CME Working Capital | 1.47 B |
Most of CME's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CME Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CME Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for CME is extremely important. It helps to project a fair market value of CME Stock properly, considering its historical fundamentals such as Working Capital. Since CME's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CME's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CME's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
In accordance with the company's disclosures, CME Group has a Working Capital of 1.47 B. This is 67.58% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. This indicator is about the same for all United States stocks average (which is currently at 1.47818092339E9).
CME Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CME's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CME could also be used in its relative valuation, which is a method of valuing CME by comparing valuation metrics of similar companies.CME is currently under evaluation in working capital category among related companies.
CME ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CME's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CME's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
CME Fundamentals
Return On Equity | 0.12 | ||||
Return On Asset | 0.0142 | ||||
Profit Margin | 0.58 % | ||||
Operating Margin | 0.62 % | ||||
Current Valuation | 78.02 B | ||||
Shares Outstanding | 360.02 M | ||||
Shares Owned By Insiders | 0.44 % | ||||
Shares Owned By Institutions | 89.87 % | ||||
Number Of Shares Shorted | 3.74 M | ||||
Price To Earning | 32.83 X | ||||
Price To Book | 2.90 X | ||||
Price To Sales | 13.94 X | ||||
Revenue | 5.58 B | ||||
Gross Profit | 5.01 B | ||||
EBITDA | 3.79 B | ||||
Net Income | 3.23 B | ||||
Cash And Equivalents | 2.22 B | ||||
Cash Per Share | 6.19 X | ||||
Total Debt | 3.88 B | ||||
Debt To Equity | 0.12 % | ||||
Current Ratio | 1.02 X | ||||
Book Value Per Share | 74.43 X | ||||
Cash Flow From Operations | 3.45 B | ||||
Short Ratio | 1.82 X | ||||
Earnings Per Share | 8.86 X | ||||
Price To Earnings To Growth | 8.70 X | ||||
Target Price | 228.85 | ||||
Number Of Employees | 3.56 K | ||||
Beta | 0.5 | ||||
Market Capitalization | 77.62 B | ||||
Total Asset | 129.84 B | ||||
Retained Earnings | 4.46 B | ||||
Working Capital | 1.47 B | ||||
Current Asset | 37.9 B | ||||
Current Liabilities | 36.82 B | ||||
Z Score | 12.19 | ||||
Annual Yield | 0.04 % | ||||
Five Year Return | 1.68 % | ||||
Net Asset | 129.84 B | ||||
Last Dividend Paid | 4.4 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Net Working Capital | 1.5 B | 1.3 B | |
Change In Working Capital | -60.8 M | -57.8 M |
Pair Trading with CME
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.Moving together with CME Stock
0.81 | MORN | Morningstar | PairCorr |
Moving against CME Stock
0.67 | DHIL | Diamond Hill Investment | PairCorr |
0.63 | MCBC | Macatawa Bank Fiscal Quarter End 31st of March 2024 | PairCorr |
0.61 | MBCN | Middlefield Banc Fiscal Quarter End 31st of March 2024 | PairCorr |
0.56 | VALU | Value Line | PairCorr |
0.51 | SPGI | SP Global Financial Report 25th of April 2024 | PairCorr |
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out CME Piotroski F Score and CME Altman Z Score analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.276 | Dividend Share 4.4 | Earnings Share 8.86 | Revenue Per Share 15.512 | Quarterly Revenue Growth 0.192 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.